41세 여성이며 난소암입니다. 2개의 CT와 1개의 PetCT 판독지입니다. 사진을 스캔하여 문자화 시킨 후 오탈자를 여러번 확인하였습니다.
요추로 전이 소견이 있었는데 pet ct 결과는 어떤지 궁금하며 이전에 찍은 ct결과도 궁금합니다.
성가시게 해드려 죄송합니다. 애가타는 환자의 어머니를 보며 부탁드립니다. 다시 한 번 죄송하며, 고마운 마음도 전합니다.
영상검사결과
진료과/병동 (의뢰처) : 부인과 (외래)
(의뢰일: 2024-05-24/
검사일: 2024-06-05 1443:20/
판독일 : 2024-06-05 17:09.56 )
임상진단명 :
Epithelial ovarian cancer unknown stage
임상소견 및 병력 :
Ovarian malig Illc
2021.3.15
s/p TAH + BSO + BPLND + PALNS + partial omentectomy+ pelvic peritoneal biopsy + Appe + cytology :
s/p CTx#6) c Genexol + Carbo: 2021.4.13-2021.8.10(6차 80%)
s/p CTx#4) c genexol + carbp + Avastin :
2차부터 80% (2022.11.30- 2023.4-06) -> severe trombocytopenia 및 neutropenia로 중단
S/p CTX(#6) c Camtobell +CDDP :
4차부터 60%(2 차부터 CDDP skip)
시행후 반응평가입니다.
검사명 :
CT: Abdomen & Pelvis Oncology Protocol (Contrast/XE) - GY,GU
[Finding]
Clinical information:Ovarian malig Ille s/p TAH + BSO + BPLND + PALNS + partial omentectomy + pelvic peritoneal biopsy + Appe + cytology: 2021.3.15s/p CTx#6) c Genexol + Carbo: 2021.4.13-2021.8.10(6차 80%)
s/p CTx(#4) C genexol + carbp + Avastin : 2차부터 80% (2022.11.30- 2023.406) -> severe trombocytopenia 및
neutropenia로 중단. /P CTX(#6) c Camtobell +CDDP : 4차부터 60%(2 차부터 CDDP skip) 시행후 반응평가입니다.
Compared with the last exam. conducted on Mar. 6th. 2024
FU CECT of the pelvis reveals
1. No change of multiple omental seeding nodules
2. Significantly enlarged pelvic or paraaortic LNs: no change of multiple pelvic and paraaortic and aorticocaval
LNS (> 10 mm)
3. Fluid: minimal
4. Pelvic orgnas (urinary bladder, rectum): unremarkable
5. Solid organs of upper abdomen: fatty liver, subcapsular seeding along the spleen, underying chronic liver disease
6. GIT: unremarkable
7. Bony pelvis: unremarkable
8. Lower lung fields: refer to the chest CT
9. Others
[Conclusion]
Ovarian cancer, Post OP. state
- no change of multiple omental seeding nodules
- no change of multiple pelvic and paraaortic LNS: suggestive of metastatic
Subcapsular seeding masses along the spleen
Minimal ascites
Underlying chronic liver disease and portal hypertension
Ovary-cancer
진료과/병동 (의뢰처) : 부인과 (외래)
(의뢰일: 2024-05-24/
검사일 : 2024-06-05 1443:22/
판독일 : 2024-06-10 08:31:02 )
임상진단명 :
Epithelial ovarian cancer unknown stage
임상소견 및 병력 :
Ovarian malig Illc
2021.3.15
s/p TAH + BSO + BPLND + PALNS + partial omentectomy+ pelvic peritoneal biopsy + Appe + cytology
s/p CTx#6) c Genexol + Carbo: 2021.4.13-2021.8.10(6차 80%)
S/P CTX(#4) C genexol + carbp + Avastin : 2차부터 80% (2022.11.30. 2023.4-06) -> severe trombocytopenia 및
neutropenia로 중단.
S/P CTX(#6) C Camtobell +CDDP : 4차부터 60%(2 차부터 CDDP skip)
시행후 반응평가입니다.
검사명 :
CT: Chest (Contrast charge free)
[Finding]
Cl: Ovarian malig Illc
Comparison: 2023-12-11
1. Near complete resolution of previously noted findings of possible bronchopneumonia, except subpleural GGOs in LUL and RLL, and linear atelectasis in RUL and LLL.No significant interval changes of the nodule (6.8mm) in RLL
2. No significant interval changes of size of LNs in mediastinum, bilateral mammary chains, left supraclavicular fossa, and right lower neck.
3. No definite visible osteolytic lesions in the bony thorax.
Upper abdomen은 복부 CT 소견을 참고하시기 바랍니다.
[Conclusion]
1. Near complete resolution of previously noted findings of possible bronchopneumonia, except subpleural GGOs in LUL and RLL, and linear atelectasis in RUL and LLL.
2. No significant interval changes of the nodule (6.8mm) in RLL
3. No significant interval changes of size of LNs in mediastinum, bilateral mammary chains, left supraclavicular fossa, and right lower neck.
Finding]
[Clinical information]
Ovarian malig Illc imp, recr (r/o bone meta)
[Findings)
Radionuclide PET scan of torso (basal skull to proximal thigh) with F-18 FDG and attenuation correction by CT without contrast enhancement reveals newly formed increased uptake at L2-3 (SUVmax: 10.1), since 2023-12-28.
It shows no interval change of the hypermetabolic lesions in the right subdiaphragmatic and right paracolic regions.
There are several hypermetabolic LNs at both lateral pelvic, abdominal regroperitoneal and right internal mammary regions, aggravated with newly formed lesions.
Otherwise, no definite abnormal uptake lesion is seen throughout the torso.
[Conclusion]
Newly formed increased uptake at L2-3 (SUVmax: 10.1), since 2023-12-28;
Spondylitis, suggestive
No interval change of the peritoneal seedings.
Aggravated nodal metastases.
첫댓글 답글 참조 바랍니다
네, 선생님.
고맙습니다.